Resource

Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes.

Goldstein, Barry J; Feinglos, Mark N; Lunceford, Jared K; Johnson, Jeremy; Williams-Herman, Debora E
Diabetes care; 2007 Aug;30(8):1979-87. PMID: 17485570
Division of Endocrinology, Diabetes, and Metabolic Diseases, Jefferson Medical College, Philadelphia, Pennsylvania, USA.
Category: 
General Reviews
Links: 
PubMed Article
Journal Article

Abstract

To assess the efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes and inadequate glycemic control on diet and exercise.